SIR, We developed a multipinhole SPECT (MPH-SPECT) imaging system with up to 20 pinholes leading to a spatial resolution <1 mm and increased sensitivity by a factor of up to 50 compared with conventional bone scintigraphy (BS) [1] . Recently, we have demonstrated that MPH-SPECT represents a feasible tool for the study of osseous alterations in IL-1 receptor antagonist-deficient mice [2] .
We report herein an initial clinical study with this newly developed method by imaging the clinically dominant hand of 13 early RA patients (ERA group, disease duration: <6 months), 9 early finger OA patients (EOA group, disease duration: <12 months, age 445 years) and 5 healthy controls (HCs). The study was approved by the local ethical committee and informed consent was obtained from all participating patients. All subjects received additional BS, and MRI was performed in the ERA patients. The number of affected joints, localization, pattern of tracer distribution and articulation involvement were semiquantitatively scored in BS and MPH-SPCET images. In the latter, quantitative analysis was also achieved by region of interest (ROI) measurements. MRI examinations were assessed according to the RA-MRI scoring system (RAMRIS) [3] and image fusion of MPH-SPECT and MRI was performed in the ERA group.
We found that MPH-SPECT imaged osseous alterations early in the disease course, when other imaging modalities remained normal: 21/22 patients had pathological MPH-SPECT. In contrast, BS showed only in 13/22 patients' pathological tracer uptake and could detect fewer joints (26 joints) with increased tracer uptake compared with MPH-SPECT (80 joints). The tracer uptake pattern on BS images was diffuse, with no distinguishing or localizing features. In contrast, improved local resolution of MPH-SPECT technique allows the definition of specific patterns and revealed significant differences between the two studied patient groups: ERA patients showed more often a central tracer distribution (10/13 ERA vs 2/9 EOA), whereas tracer uptake of EOA patients can be described as 'hemispheric', resembling more an eccentric pattern (7/9 EOA vs 2/13 ERA). The appearance of different uptake patterns in single finger joints with nuclear imaging is new. So far, an anatomic understanding of the earliest stages of ERA and EOA may have important implications for elucidating its pathogenesis, rather than for clinical diagnosing [4, 5] . The more centrally localized tracer uptake in our ERA patients probably reflects what happens in pre-erosive lesions: an osteoclastic activity combined with reactive attempts during bone repair and matches with MRI studies analysing osteoedema localization in arthritis [6, 7] . The eccentric tracer distribution in EOA might be interpreted as the beginning of very early osteophytic reactions at the insertions of the collateral ligaments of the small finger joints, which was demonstrated in MRI analysis of other study groups in patients with early hand OA [5] .
The quantitative analysis of activity accumulation in HCs and patients ranged from 4.50 to 222.70 normalized counts. In contrast, we found higher ROI values in affected joints in the patient group compared with HCs. The tracer uptake in the mainly affected joint was two to six times higher than in unaffected joints in a single patient. Comparing the individual joint uptake we found, on average, slightly higher values in the ERA group (3.58 times higher in EOA, 3.64 in ERA), but a distinction between EOA and ERA merely on the basis of the degree of increased bone metabolism was not possible (P < 0.59 using a two-tailed unpaired t-test). In contrast, the mean uptake values were slightly higher in the EOA patients than in ERA patients (78.75 vs 62.16). Within the ERA group, comparing affected and unaffected joints, significances were determined at P < 0.002 and in the EOA group at P < 0.024 using a two-tailed paired t-test.
The correlation of MRI and MPH-SPECT findings revealed that oedema and erosions matched with the localization of maximal tracer accumulation in 11/13 patients (Fig. 1) . In 2/13 ERA patients, the signal of the cortical bone, as well as the bone marrow signal, appeared normal in all MRI sequences (RAMRIS score 0). In these joints (three MCP II joints and two MCP III joints), only soft tissue inflammation (synovitis) was evident in MRI. In contrast, MPH-SPECT revealed increased bone metabolism and the overlaid images of MRI and MPH-SPECT confirmed that the areas of increased bone metabolism were localized in bone matrix that appeared tomographically normal in MRI (Fig. 1) , indicating that normal bone signal in MRI does not exclude the beginning of bony alterations.
In summary, MPH-SPECT provides increased sensitivity, high image resolution, accurate quantitation and compatibility with conventional SPECT cameras. MPH-SPECT allows the imaging very initial bony alterations in great detail in ERA and EOA, which could not be depicted by other imaging modalities, including MRI. These qualities make the technique optimal for researchers and clinicians who desire to bridge the gap between pre-clinical and clinical testing.
Rheumatology key message
Revealing new insights and aspects of bony alterations in early arthritis, MPH-SPECT might be an important research tool in the future. 
